| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.031 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.028 | 0.8 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |